Abstract:Introduction: Previous studies have revealed that Gleason score upgrading (GSU) was closely related to an increased biochemical recurrence rate and adverse oncologic outcomes in patients with prostate cancer (PC). Therefore, we performed a meta-analysis to determine the predictive factors for GSU following radical prostatectomy (RP). Methods: We performed an extensive literature search using PubMed, Embase, and Cochrane in September 2022. In order to calculate the pooled odds ratio (OR), standardized mean difference (SMD), and 95% confidence intervals, a fixed effect or a DerSimonian and Laird random effect was applied. Results: Twenty-six studies included 18,745 PC patients that were available for further analysis. Our results revealed that GSU was significantly correlated with age (summary SMD = 0.13; p = 0.004), prostate volume (PV) (summary SMD = -0.19;p < 0.001), preoperative PSA (p-PSA) (summary SMD = 0.18; p < 0.001), PSA density (PSAD) (summary SMD = 0.40; p < 0.001), number of positive cores (summary SMD = 0.28; p = 0.001), percentage of positive cores (summary SMD = 0.36; p < 0.001), Prostate Imaging Reporting and Data System (PIRADS) scores (>3/<= 3) (summary OR = 2.27; p = 0.001), clinical T stage (>T2/<= T2) (summary OR = 1.73; p < 0.001), positive surgical margins (PSM) ( summary OR = 2.12; p < 0.001), extraprostatic extension (EPE) (summary OR = 2.73; p < 0.001), pathological T stage (>T2/<= T2) (summary OR = 3.45; p < 0.001), perineural invasion (PNI) (summary OR = 2.40; p = 0.008), and neutrophil to lymphocyte ratio (NLR) (summary SMD = 0.50; p < 0.001). However, we found that GSU was not significantly correlated with body mass index (BMI) (summary SMD = -0.02; p = 0.602). Moreover, our sensitivity and subgroup analyses showed that the findings were reliable. Conclusions: Age, PV, p-PSA, PSAD, number of positive cores, percentage of positive cores, PI-RADS score, clinical T stage, PSM, EPE, pathological T stage, PNI, and NLR are independent factors predicting GSU following RP. The findings may be helpful in risk stratification and personalized treatment in PC patients. (c) 2023 S. Karger AG, Basel

Predictors of Gleason Grading Group Upgrading in Low-Risk Prostate Cancer Patients From Transperineal Biopsy After Radical Prostatectomy

Predictive risk factors for Gleason score upgrading of low-risk prostate cancer

[Clinically Predictive Factors of Gleason Score Upgrading in Patients after Radical Prostatectomy].

Predictive risk factor for Gleason score upgrading in low risk prostate cancer after radical prostatectomy

Predictive Factors for Gleason Score Upgrading in Patients with Prostate Cancer after Radical Prostatectomy: A Systematic Review and Meta- Analysis

Risk factors of Gleason score upgrade in patients undergone radical prostatectomy

Comparing Histology Between Prostate Cognitive Fusion Targeted Biopsy and Radical Prostatectomy: Exploring Risk Factors of Gleason Score Upgrading in Chinese Patients.

The Prognostic Value of 18F-PSMA-1007 PET/CT in Predicting Pathological Upgrading of Newly Diagnosed Prostate Cancer from Systematic Biopsy to Radical Prostatectomy

Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillance

Value of Prostate-Specific Antigen Density in Predicting an Upgrade in Gleason Score for Initial Prostate Biopsy

[Influence of Clinical Factors on Gleason Score Upgrade in Patients Undergoing Radical Prostatectomy].

Factors Predicting 2014 ISUP Pathology Grade Upgrading from Prostate Biopsy to Radical Prostatectomy Pathology

Machine learning prediction of Gleason grade group upgrade between in-bore biopsy and radical prostatectomy pathology

Risk of upgrading from prostate biopsy to radical prostatectomy pathology: Is magnetic resonance imaging-guided biopsy more accurate?

Prostate Health Index (phi) and its derivatives predict Gleason score upgrading after radical prostatectomy among patients with low-risk prostate cancer

Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort

Management of prostate cancer patients with locally adverse pathologic features after radical prostatectomy: feasibility of active surveillance for cases with Gleason grade 3 + 4 = 7

Nomograms for Predicting Gleason Upgrading in a Contemporary Chinese Cohort Receiving Radical Prostatectomy after Extended Prostate Biopsy: Development and Internal Validation

Upgrade in Gleason Score Between Biopsy and Radical Prostatectomy Pathology Indicates Poor Outcomes in Prostate Cancer

PI-RADS v2 and periprostatic fat measured on multiparametric magnetic resonance imaging can predict upgrading in radical prostatectomy pathology amongst patients with biopsy Gleason score 3 + 3 prostate cancer.

Low Serum Testosterone Predicts Upgrading and Upstaging of Prostate Cancer after Radical Prostatectomy